Related Experiment Video
Updated: Jun 7, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
Charles J David1, James L Manley
1Department of Biological Sciences, Columbia University, New York, New York 10027, USA.
Abstract:
Alternative splicing of mRNA precursors is a nearly ubiquitous and extremely flexible point of gene control in humans. It provides cells with the opportunity to create protein isoforms of differing, even opposing, functions from a single gene. Cancer cells often take advantage of this flexibility to produce proteins that promote growth and survival. Many of the isoforms produced in this manner are developmentally regulated and are preferentially re-expressed in tumors. Emerging insights into this process indicate that pathways that are frequently deregulated in cancer often play important roles in promoting aberrant splicing, which in turn contributes to all aspects of tumor biology.
Insights
Alternative splicing allows human cells to create diverse protein functions from one gene. Cancer cells exploit this to produce proteins that enhance growth and survival, contributing to tumor development.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Biology
Background:
- Alternative splicing of messenger RNA (mRNA) precursors is a fundamental gene regulation mechanism in humans.
- This process enables the generation of multiple protein isoforms with distinct or opposing functions from a single gene.
- Cancer cells frequently utilize alternative splicing to produce proteins that support tumor growth and survival.
Purpose of the Study:
- To investigate the role of alternative splicing in cancer.
- To understand how deregulated cellular pathways contribute to aberrant splicing in tumors.
- To elucidate the contribution of alternative splicing to tumor biology.
Main Methods:
- Analysis of mRNA precursor splicing patterns.
- Identification of alternatively spliced isoforms in cancer.
- Investigation of signaling pathways involved in aberrant splicing.
Main Results:
- Alternative splicing is a key mechanism for generating functional diversity in proteins.
- Cancer cells re-express developmentally regulated isoforms, promoting malignancy.
- Deregulation of common cancer pathways drives aberrant splicing, impacting tumor progression.
Conclusions:
- Alternative splicing is a critical and flexible mechanism of gene control exploited by cancer.
- Aberrant splicing, driven by deregulated cancer pathways, significantly contributes to all facets of tumor biology.
- Targeting aberrant splicing pathways presents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
What is Gene Expression?
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

